Irukandji

Irukandji refers to several species of extremely small, venomous jellyfish in the class Cubozoa that inhabit warm coastal waters of northern Australia and nearby regions in the western Pacific and Indian Oceans. These jellyfish are best known for causing Irukandji syndrome in humans, a set of severe symptoms resulting from envenomation.

Physically, Irukandji medusae are among the smallest jellyfish, typically about 1 to 2.5 cm in bell diameter, and are often transparent, making them easy to miss in the water. They have the characteristic cube-shaped bell and long, untidy tentacles or tentacle clusters. The most well-known species is Carukia barnesi; other species associated with the Irukandji name include Malo kingi and several related Carukia/Malo taxa.

Habitat and distribution: Irukandji jellyfish inhabit shallow coastal environments such as bays, mangroves, and seagrass beds, particularly around northern and eastern Australia. They can be present in subtropical waters and are more commonly encountered during the warmer months, though stings can occur year-round in some areas.

Irukandji syndrome: Envenomation can produce severe, generalized pain exceeding the sting site, typically accompanied by nausea, vomiting, sweating, anxiety, and restlessness. Systemic effects may include hypertension, tachycardia, and in rare cases pulmonary edema or shock. Onset is usually within 20 to 60 minutes after contact, but can vary.

First aid and treatment: Carefully remove visible tentacles with tweezers or a stiff card, rinse the area with seawater, and avoid rubbing. There is no widely available specific antivenom; management focuses on analgesia, antiemetics, and supportive care in a hospital setting. Some cases have used intravenous magnesium sulfate and careful blood pressure management. Prevention includes protective swimwear and awareness of jellyfish warnings in coastal areas.